Treatment of early and refractory dermatomyositis with infliximab: A report of two cases

Clinical Rheumatology

Volumn 26, Issue 7, 2007, Pages 1186-1188

  Dold, Sylvia ^a   Justiniano, Maria E ^a   Marquez, Javier ^a   Espinoza, Luis R ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dermatomyositis; Inflammatory myopathy; Infliximab; Polymyositis; Tumor necrosis factor

Indexed keywords

HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE; PREDNISONE;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; ASPIRATION PNEUMONIA; BACTEREMIA; CASE REPORT; CLINICAL FEATURE; DERMATOMYOSITIS; DIZZINESS; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG RESPONSE; DYSPHAGIA; FEMALE; HEART PALPITATION; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; MAINTENANCE THERAPY; MUSCLE ATROPHY; MUSCLE BIOPSY; MUSCLE NECROSIS; MUSCLE WEAKNESS; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMAPHERESIS; PRIORITY JOURNAL; RASH; RESPIRATORY FAILURE; THORAX PAIN; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; ANTIBODIES, MONOCLONAL; DERMATOLOGIC AGENTS; DERMATOMYOSITIS; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HUMANS; HYDROXYCHLOROQUINE; METHYLPREDNISOLONE; PREDNISONE; TREATMENT OUTCOME;

EID: 34249914757     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-006-0325-z     Document Type: Article

References (17)

1. Bohan A, Peter JB (1975) Polymyositis and dermatomyositis. N Engl J Med 292:344-347, 403-407
2. Marie I, Hachulla E, Hatran PY et al (2001) Polymyositis and dermatomyositis: Short term and long term outcome, and predictive factors of prognosis. J Rheumatol 28:2230-2237
3. Airio A, Kautiainen H, Hakala M (2006) Prognosis and mortality of polymyositis and dermatomyositis patients. Clin Rheumatol 25:234-239
4. Choy EH, Isenberg DA (2002) Treatment of dermatomyositis and polymyositis. Rheumatology (Oxford) 41:7-13
5. Agarwal SK, Monach PA, Docken WP, Coblyn JS (2005) Characterization of relapses in adult idiopathic inflammatory myopathies. Clin Rheumatol 24:1-6
6. Takada K, Nagasaka K, Miyasaka N (2005) Polymyositis/dermatomyositis and interstitial lung disease: A new therapeutic approach with T-cell-specific immunosuppressants. Autoimmunity 38:383-392
7. Levine TD (2005) Rituximab in the treatment of dermatomyositis: An open label study. Arthritis Rheum 52:601-607
8. Edge JC, Outland JD, Dempsey JR, Callen JP (2006) Mycophenolate mofetil as an effective corticosteroid-sparing therapy for recalcitrant dermatomyositis. Arch Dermatol 142:65-69
9. Oryoji K, Himaji D, Nagafuji K et al (2005) Successful treatment of rapidly progressive interstitial pneumonia with autologous peripheral blood stem cell transplantation in a patient with dermatomyositis. Clin Rheumatol 24:637-640
10. Korkmaz C, Tamiz C, Cetinbas F, Buyukkidan B (2004) Successful treatment of alveolar hypoventilation due to dermatomyositis with anti-tumor necrosis factor-alpha. Rheumatology (Oxford) 43:937-938
11. Anandacoomarasamy A, Howe G, Manolios N (2005) Advanced refractory polymyositis responding to infliximab. Rheumatology 44:562-563
12. Keystone EC (2004) The utility of tumor necrosis factor blockade in orphan diseases. Ann Rheum Dis 63(Suppl 2):iI79-ii83
13. Kuru S, Inukai A, Liang Y, Doyu M, Takano A, Sobue G (2000) Tumor necrosis factor-alpha expression in muscles of polymyositis and dermatomyositis. Acta Neuropathol 99:585-588
14. Shimizu T, Tomita Y, Son K, Nishinarita S, Sawada S, Horie T (2000) Elevation of serum soluble tumor necrosis factor receptor in patients with polymyositis and dermatomyositis. Clin Rheumatol 19:352-359
15. Pachman LM, Liotta-Davis MR, Hong DK et al (2000) TNFalpha-308A allele in juvenile dermatomyositis: Association with increased production of tumor necrosis factor alpha, disease duration, and pathologic calcifications. Arthritis Rheum 43:2368-2377
16. Hengstman GJD, van den Hoogen FHJ, Barrera P, Netea MG, Pieterse A, van den Pute LBA et al (2003) Successful treatment of dermatomyositis and polymyositis with anti-tumor necrosis factor-alpha: Preliminary observations. Eur Neurol 50:10-15
17. Hengstman GJD, van den Hoogen FHJ, van Engelen BGM (2004) Treatment of dermatomyositis and polymyositis with anti-tumor necrosis factor-alpha: long-term follow-up. Eur Neurol 52:61-63